Hepatitis B among Inuit: A review with focus on Greenland Inuit

Table 1 Studies of hepatitis B virus markers among Inuit populations

Country	Ref.	HBsAg	Anti-HBs	Anti-HBc	HBeAg	Anti-HBe	Participants	Year
		%	%	%	%	%	Inuit/n
Greenland
	Skinhoj et al[12]	7.1					2904/2904	1974
	Skinhoj et al[13]	16.61	45.81	41.61	62	303	1450/1450	1977
	Skinhøj et al[16]	16.7	23.6		0.0	2.6	191/254	1979
	Melby et al[17]	0-204	0-354				193/371	1984
	Olsen et al[8]	11.55					NA/1893	1989
	Langer et al[15]	7.0		42.0	0.4		503/503	1997
	Krarup et al[9]	20					434/434	2008
	Børresen et al[14]	18.9		62.6	4.3		185/185	2010
	Børresen et al[18]	7.8		37.4			NA/8879	2011
	Rex et al[20]	4.4			0.0		136/136	2012
Canada
	Minuk et al[21]	4.05			0.0	3.83	671/720	1982
	Larke et al[7]	3.9	24.5		8.82		8282/14198	1987
	Baikie et al[22]	6.9		26.4	0.02		766/2156	1989
Alaska
	Schreeder et al[23]	6.4	17.8				3053/3053	1983
Russia
	Ohba et al[24]	11.85	35.95				NA/348	1999

¹Calculated from randomly selected samples;

²Among all HBsAg positive tested for HBeAg;

³Among all HBsAg positive tested for anti-HBe;

⁴Age specific prevalences;

⁵Among all studied. HBeAg: Hepatitis B e-antigen; HBsAg: Hepatitis B surface antigen; Anti-HBc: Hepatitis B core antibody; Anti-HBs: Hepatitis B surface antibody; Anti-HBe: Hepatitis B e antibody; NA: Not analyzed.